Shanghai Obio Technology (Group) (SHSE:688238) FFO


SHSE:688238 Shanghai Obio Technology (Group) Corp Ltd SHSE:688238
63 GF Score
Price ¥5.82
GF Value ¥7.80
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Obio Technology (Group) FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:688238
63GF Score
Shanghai Obio Technology (Group) Corp Ltd SHSE:688238
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Obio Technology (Group) (SHSE:688238) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Obio Technology (Group) stock appears to be undervalued. The current stock price of ¥5.82 is trading 25.4% below its estimated GF Value™ of ¥7.80. GuruFocus considers Shanghai Obio Technology (Group) to be Modestly Undervalued.

Key valuation signals for SHSE:688238:

  • FFO:
  • GF Value™: ¥7.80 vs. price of ¥5.82 (25.4% below fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688238 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Obio Technology (Group) Business Description

Address Lane 908, Ziping Road, Building 19, International Medical Park, Pudong New Area, Shanghai, CHN, 201318
Shanghai Obio Technology (Group) Corp Ltd provides contract research organization (CRO) services, including gene therapy vector development and gene function research for basic research, as well as contract development and manufacturing organization (CDMO) services, including IND-enabling CMC research and GMP production of clinical samples for gene therapy drug development.
63GF Score

Get the complete analysis for SHSE:688238

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.82
Price
¥7.80
GF Value